Nukkleus Inc. (NASDAQ:NUKK - Get Free Report) was the recipient of a large growth in short interest during the month of May. As of May 31st, there was short interest totalling 259,500 shares, a growth of 27.3% from the May 15th total of 203,800 shares. Based on an average daily volume of 168,300 shares, the days-to-cover ratio is currently 1.5 days. Approximately 6.4% of the company's stock are short sold.
Nukkleus Trading Down 8.6%
Shares of NASDAQ NUKK traded down $1.00 during mid-day trading on Friday, reaching $10.57. 361,959 shares of the company were exchanged, compared to its average volume of 1,437,355. Nukkleus has a 1 year low of $1.30 and a 1 year high of $78.32. The firm has a 50-day moving average of $14.82 and a 200 day moving average of $17.69.
Nukkleus (NASDAQ:NUKK - Get Free Report) last released its quarterly earnings results on Friday, May 23rd. The company reported $18.19 EPS for the quarter.
Institutional Investors Weigh In On Nukkleus
An institutional investor recently bought a new position in Nukkleus stock. Compagnie Lombard Odier SCmA purchased a new position in Nukkleus Inc. (NASDAQ:NUKK - Free Report) in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm purchased 6,200 shares of the company's stock, valued at approximately $74,000. Compagnie Lombard Odier SCmA owned approximately 0.13% of Nukkleus as of its most recent filing with the Securities and Exchange Commission (SEC). Institutional investors and hedge funds own 12.47% of the company's stock.
Analysts Set New Price Targets
Separately, Wall Street Zen upgraded Nukkleus from a "sell" rating to a "hold" rating in a research note on Friday, May 30th.
View Our Latest Stock Analysis on NUKK
Nukkleus Company Profile
(
Get Free Report)
Nukkleus Inc, a financial technology company, provides blockchain-enabled technology solutions worldwide. It focuses on providing software and technology solutions for retail foreign exchange trading industry. The company provides transactions platform for dealing and risk management services. It also offers cross-border payment and transactions solutions and blockchain-enabled financial services solutions to institutional investors.
Featured Stories
Before you consider Nukkleus, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Nukkleus wasn't on the list.
While Nukkleus currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
